Acurx Pharmaceuticals Inc expected to post a loss of 27 cents a share - Earnings Preview

Acurx Pharmaceuticals

11/08/2023 15:58

* Acurx Pharmaceuticals Inc  ACXP.OQ   ACXP.O  is expected
to report results on August 14.
    * 
    * ​Refinitiv's mean analyst estimate for Acurx
Pharmaceuticals Inc
is for a loss of 27 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Acurx
Pharmaceuticals Inc is $14​, above​ its last closing price
of $1.81. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.30       -0.29      -0.25     Beat    15.3
 Dec. 31 2023  -0.35       -0.35      -0.28     Beat    20
 Sep. 30 2022  -0.27       -0.28      -0.32     Missed  -14.3​
 ​​Mar.                    -0.33      -0.26     Beat    21.2
 31 2022                                                
 Dec. 31 2021  -0.40       -0.40      -0.22     Beat    45​
 This summary was machine generated August 11 at 14:58 GMT.  All
figures in US dollars  unless otherwise stated